In this issue:
- Government of Canada Supports Promising Medical Research at the University of Manitoba
- Province Invests in Science Education With Expanded Partnerships
- Best-ever Bottom Line for IMRIS
- Two New DEKALB® 73 Series Canola Hybrids Recommended for Registration
Life Science in the News
- BIO/Ipreo Study Shows Investors Optimistic on Biotech’s Future
- DuPont Expanding Soybean Research Facilities
- Private Member Bill Would Add More Scrutiny to Approval Process of New Genetically Modified Seeds
- Success Rates for Experimental Drugs Falls: Study
- Sanofi-Aventis to buy Genzyme for $20.1 billion cash
- FDA’s Rules for Follow-on Biologics Coming `Very Soon’
Access the newsletter here.
About the Life Science Association of Manitoba (LSAM):
LSAM represents all those involved in the Life Science Sector in Manitoba. The Life Science Sector focuses on the use of innovative biological tools and products, the creation of wealth and sustainability in the production of medical treatments, diagnostics, more-nutritional foods, energy, chemicals, and materials, while improving the quality of the environment.
The Life Science sector is a key to economic growth within the Province of Manitoba and is currently estimated to contribute more than 7% of the province’s GDP. In addition to generating value on its own, the Life Science sector is helping to grow and sustain competitiveness in ailing and traditional sectors of the economy, through the application of new and innovative products and processes.
To find out more about LSAM visit its website here.